AngioDynamics (ANGO) Tops Q3 EPS by 4c; Adjusted FY17 Revs Lower, EPS Higher

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to AngioDynamics (ANGO) Tops Q3 EPS by 4c; Adjusted FY17 Revs Lower, EPS Higher

AngioDynamics Reports Fiscal 2017 Third Quarter Results

March 30, 2017 6:00 AM EDT

Q3 net sales of $85.6 million, down 2% year-over-yearQ3 GAAP earnings per share of $0.08; non-GAAP adjusted EPS up 27% from Q3 fiscal 2016 Q3 operating cash generation of $14.4 million; free cash flow generation of $14.0 millionRevised FY2017 revenue and adjusted EPS guidance; free cash flow guidance unchanged

ALBANY, N.Y., March 30, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the 2017 fiscal year third quarter... More